HVAX Technologies Limited specializes in providing turnkey cleanroom and controlled environment infrastructure solutions aimed at the pharmaceutical, healthcare, hospital, and biotech sectors.

The company is expanding into the healthcare infrastructure segment with a proposed acquisition of Krew Instruments, which aligns with HVAX's vision to diversify its portfolio.

HVAX shows strong growth momentum with a current order book of INR350 crores and a pipeline worth INR650 crores, showcasing its ability to convert opportunities into financial successes.

Their strategy involves expanding operations through strategic partnerships and acquisitions, enhancing capabilities and establishing footholds in the healthcare market.

HVAX anticipates a revenue growth of 35% year-on-year, driven by strategic expansions, operational efficiency, and a robust order pipeline in pharmaceuticals and emerging sectors.